ImmuBYTES Session 3 Video Recording
DateCategory Watching Time 21 Minutes https://immuone.com/wp-content/uploads/2025/07/ImmuONE.mp4 Get in touch Add a Comment Related Posts
ImmuBYTES Session 3 Video Recording Read More »
DateCategory Watching Time 21 Minutes https://immuone.com/wp-content/uploads/2025/07/ImmuONE.mp4 Get in touch Add a Comment Related Posts
ImmuBYTES Session 3 Video Recording Read More »
In ImmuBYTES Session 3, “Looking Beyond Baseline Deviations for Lung and Immune Safety,” Prof. Victoria Hutter (CSO & Co-founder) highlighted how subtle changes in macrophage morphology can uncover early immune and lung effects.
Looking beyond the baseline: new frontiers in lung and immune safety Read More »
Early detection of pulmonary ADC toxicity using ImmuONE’s morph_ONE™ high-content imaging assay of alveolar macrophages to improve safety and efficacy in ADC drug development.
Immune cells are reshaping inhalation toxicology by offering deeper insights into respiratory and systemic effects of tested compounds. In the second ImmuBYTES webinar, ‘Immune cells as predictive tool for toxicology’, Dr. Ewelina Hoffman highlighted the crucial role of alveolar macrophages in improving preclinical safety assessments. Key highlights include: 1. Immune cells & alveolar macrophages As
A UK biotech start-up with a 3D human lung model that provides an alternative to animal testing has raised a further £600,000 from the Midlands Engine Investment Fund, Mercia Ventures and Pioneer Group. ImmuONE’s laboratory model is used to test new drugs, chemicals or consumer products to provide evidence they are safe to use. The
ImmuONE raises £600K in investment for ‘3D lung’ to replace animal testing Read More »
Welcome to ImmuBYTES, a new series designed to deliver bite-sized insights into cutting-edge tools in cell-based research and toxicology to drive innovation and discovery.
ImmuBYTES: a series of short webinars Read More »
In our recent ImmuBYTES webinar, we delved into the fascinating world of Cell Painting, a high-content imaging assay (HCIA) that transforms cellular morphology into a rich source of data.
Unveiling the Art of Image Analysis with Cell Painting Read More »
Gender equality in the biotech industry has come a long way in recent years. In the UK, the US and Europe, women now make up between 40-50% of the biotech workforce, which is a higher percentage than in other STEM fields, such as engineering and the physical sciences.
Celebrating Triple Triumph at the Inspiring Herts Awards 2024 Read More »
Gender equality in the biotech industry has come a long way in recent years. In the UK, the US and Europe, women now make up between 40-50% of the biotech workforce, which is a higher percentage than in other STEM fields, such as engineering and the physical sciences.
Advancing Lung Toxicology: The Future of High Content Image Analysis Read More »
Dr. Verma joins us for a coffee to share his diverse journey from studying human and medical genetics to his groundbreaking work in genetic toxicology. Discover what drives Dr. Verma’s dedication to developing new genetic toxicity testing at ImmuONE.
Our Scientific Lead in Genetic Toxicology, meet Dr Verma! Read More »